Riskpilot← Back to searchSign inGet full accessSkinBy Sandra Remnestedt AB
ABActiveOrg 5592898034Birger Jarlsgatan 111 AOther non-specialised retail sale · NACE 4712Est. 20201 employees
Revenue 2026
SEK 151K
-18% vs 2025
EBITDA margin
-24.9%
+51% vs 2025
Equity ratio
55.1%
Financial strength
Net profit 2026
SEK -37K
+51% vs 2025
| Revenue | SEK 151K | -18% |
| EBITDA | SEK -38K | +51% |
| Net profit | SEK -37K | +51% |
| Total assets | SEK 23K | -67% |
| Equity | SEK 12K | -75% |
| Employees | 1 | — |
Legal name
SkinBy Sandra Remnestedt AB
Org number
5592898034
Legal form
Aktiebolag
NACE code
4712 · Other non-specialised retail sale
Founded
14 december 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2026-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget bedriver en holistisk hudvårds salong inriktad på hela kroppen inifrån och ut. Utföranden av olika skönhets behandlingar, apparaturer, makeup, massage och hälsocoaching. Bolaget säljer hudvårdsprodukter, makeup och kosttillskott på salongen och via webbshop.
Address
Birger Jarlsgatan 111 A
Email
info@skinby.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 1 943 | 1 397 | 782 | 183 | 151 |
| Staff expenses | — | −411 | −84 | −53 | −13 |
| EBITDA | 225 | 125 | 121 | −76 | −38 |
| Depreciation & amort. | −44 | −44 | — | — | — |
| EBIT | 181 | 81 | 121 | −76 | −38 |
| Net financials | — | −0 | −0 | 0 | 0 |
| Profit before tax | 182 | 80 | 120 | −76 | −37 |
| Tax | −42 | −18 | −27 | — | — |
| Net profit | 140 | 62 | 94 | −76 | −37 |
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Total assets | 262 | 183 | 179 | 69 | 23 |
| Equity | 165 | 102 | 126 | 50 | 12 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 97 | 81 | 53 | 19 | 10 |
| Total debt | 97 | 81 | 53 | 19 | 10 |
EBITDA margin
-24.9%
This company
15.8%
Market median
-258% vs market
20222026
Equity ratio
55.1%
This company
38.2%
Market median
+44% vs market
20222026
Return on equity
-299.5%
This company
18.4%
Market median
-1728% vs market
20222026
Net profit margin
-24.7%
This company
8.1%
Market median
-405% vs market
20222026
Asset turnover
6.68×
This company
1.12×
Market median
+496% vs market
20222026
Debt / equity
0.82×
This company
0.62×
Market median
+32% vs market
20222026
- Annual report 2026Filed via Bolagsverket / SCB · Period 2025-04-01 – 2026-03-31
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2020-12-01 – 2022-03-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SkinBy Sandra Remnestedt AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sandra Maria Irene Remnestedt | Board of Directors | 0 companies |
| Hans Olov Remnestedt | Deputy Board Member | 0 companies |